-
Legence Corp (LGN) PT Raised to $47 at Stifel on Bowers Deal, Fabrication Sales
-
Jefferies Upgrades Legence Corp (LGN) to Buy
-
Legence Corp (LGN) PT Raised at BMO Capital as 'Q3/25 Results Deliver On All Fronts'
-
Legence Corp (LGN) PT Raised to $48 at RBC Capital
-
Bernstein on Legence Corp (LGN): 'We're Buyers Following the 20% Move'; PT Raised to $53
-
Legence Corp. (LGN) Reports Q3 Loss of $0.02 ; Offers Guidance
-
Roth/MKM Starts Legence Corp (LGN) at Buy
-
Vertical Group Starts Legence Corp (LGN) at Buy
-
BofA Securities Starts Legence Corp (LGN) at Buy
-
Guggenheim Starts Legence Corp (LGN) at Buy
-
Wolfe Research Starts Legence Corp (LGN) at Outperform
-
BTIG Starts Legence Corp (LGN) at Buy
-
Barclays Reiterates Equalweight Rating on Legence Corp (LGN)
-
Rothschild Redburn Starts Legence Corp (LGN) at Buy
-
Goldman Sachs Starts Legence Corp (LGN) at Buy
-
Jefferies Starts Legence Corp (LGN) at Hold
-
Bernstein SocGen Group Starts Legence Corp (LGN) at Outperform
-
BMO Capital Starts Legence Corp (LGN) at Outperform
-
Stifel Starts Legence Corp (LGN) at Buy
-
RBC Capital Starts Legence Corp (LGN) at Outperform
-
Legence (LGN) Opens At $27, IPO Priced At $28
-
Legence launches roadshow for its IPO
-
Legence (LGN) files for proposed Nasdaq IPO
-
Legence files for proposed Nasdaq IPO

